• No notifications yet.
  • Sign Out
logo image
  • logo image
Registered User? Login
Forgot Password?
Sign Up
loader image
New User? Sign Up
Forgot Password?
Login
loader image

    Breast Cancer: Adjuvant Treatment for Early-Stage, HR+ Invasive Breast Cancer

    Moderated by Dr. Neil Iyengar

    During this conversation, we will explore adjuvant therapy for HR+, early-stage breast cancer. We will cover two clinical cases that are designed to foster discussion of how we are using targeted therapy in the adjuvant setting for eligible patients.

    Interested in joining the Targeted Oncology™ Case-Based Roundtable® ?  In-person seating is limited to 14 participants.

    This discussion is taking place around the PER® 23rd Annual School of Breast Oncology.

    To be eligible to attend this meeting, physicians must be practicing medical oncologists or hematologists treating patients for the specified tumor type and located within the event region.

    Please note that fellows are not eligible to attend this meeting unless otherwise specified.

    This discussion is IN-PERSON only, there are no virtual options. 

    CASE-BASED ROUNDTABLE DETAILS

    DATE & TIME

    Wednesday, November 5, 2025
    7:00 PM - 9:00 PM ET
     

    EVENT VENUE

    Davio's Northern Italian Steakhouse

    3500 Peachtree Rd NE, Atlanta, GA 30326


    Moderator

    Join Targeted Oncology for a collaborative, small-group meeting designed around case-based clinical profiles and peer-dialogue led by an expert physician.  This session offers practicing oncologists the perfect opportunity to sharpen their skills and expertise in treatment strategies.



    image placeholder
    NI
    Neil Iyengar, MD
    Co-Director & Director
    Winship Cancer Institute at Emory University

    VENUE LOCATION

    Davio's Northern Italian Steakhouse3500 Peachtree Rd NE, Atlanta, GA 30326, USA

    The Value of Targeted Oncology Discussions

    "Targeted Oncology provides educational materials that I can bring to my practice that can influence the way I practice each day. It’s a great opportunity to find out what peers are doing and see what the latest data shows as well." - Jason Levitz, MD

    "Attending these discussions is a great way to get a sense of the latest and greatest. Right now in oncology, it’s hard to keep up with everything—there’s constantly new data coming out of conferences. Having someone put that into context - while you’re also able to discuss cases with community members and fellow physicians, is a great way to stay up to date to and educated." - Andrew Lipsky, MD

    "Targeted Oncology discussions have influenced my clinical practice by helping me learn what other community oncologists are doing. I think it’s great to attend these forums where collectively we can learn from each other how to continue treating our patients the best way possible." - Eshan Patel, MD, MBA

    MARKET RESEARCH PARTICIPATION

    This event is held in partnership with Healthcare Research & Analytics to gain market research insights into health care professional’s educational needs in their current practice setting.   


    HRA® offers compensation of $650 to oncologists for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey.



    Targeted Healthcare Communications® — an MJH Life Sciences® Brand

    259 Prospect Plains Rd., Building H, Monroe, NJ 08831

    Copyright 2025 © Intellisphere, LLC.  All Rights Reserved.

    Terms & Conditions

    Privacy Policy

     

    Do Not Sell My Info
Looking for your ticket? Contact the organizer
Looking for your ticket? Contact the organizer